Cork doctor Niamh Lynch has warned about a childhood virus doing the rounds 'hated more than RSV', warning that adenovirus has a huge array of symptoms and can hit children particularly hard ...

Theriva Biologics is putting more of its eggs in the VCN-01 basket as it unveils a change-up in its R&D focus. | Theriva ...

Learn how viruses lingering in sewage can enter bodies of water, posing a public health risk that may be on the rise as ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

For four weeks, emergencies and consultations of pediatricians and pulmonologists for minors and adults have been full of ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Climate change is leading to more extreme weather events, raising the likelihood of exposure to harmful viruses from ...

Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat ...

The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in ...

The conference call can be accessed using the following information: Date: Thursday, March 20, 2025 - 4:30 p.m. ET Investors may submit written questions in advance of the conference call to ir@vaxart ...